- 积分
- 0
- 威望
- 0
- 包包
- 23
|
本帖最后由 细胞海洋 于 2011-10-20 13:25 编辑 * Z% v7 e' p. `3 k1 g
! ~# W: r5 j' b; Q8 |* W' bZhiqiang An, "Therapeutic Monoclonal Antibodies: From Bench to Clinic" 2 a+ q! U" Q- G+ r
Wiley | 2009 | ISBN: 0470117915 | 905 pages | PDF | 11,4 MB
/ F! E! m2 O9 M3 }0 T. f
+ K, N+ G# f. W7 ?8 v+ V70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies.
5 w( m3 m# i% c, T& DFirst book to address the discovery and development of antibody therapeutics in their entirety.
; `6 }# @ t8 c* `; ^6 dMost chapters contain experimental data to illustrate the principles described in them.
6 t3 `- y7 v+ c: Q* cAuthors provide detailed methodologies that readers can take away with them and use in their own laboratories( _0 V6 {3 s2 Z: B0 L
2010-7-12 18:23:52 上传下载附件 (32.22 KB) . H' y7 R' w0 s2 `
6 c8 D* H, C! u( M. L
THERAPEUTIC MONOCLONAL ANTIBODIES -146 d3 G9 d" w0 }+ m7 m* E
CONTENTS -12
' w( c4 L% C, f/ z( L FOREWORD -8# E6 L6 U. X2 i: o
PREFACE -6
0 |+ T; d6 w7 |, m$ ~9 _ D$ S CONTRIBUTORS -4! l) P6 q6 S8 s0 }
PART I ANTIBODY BASICS 1 a3 z) F; z8 d- j+ {
1. Therapeutic Monoclonal Antibodies: Past, Present, and Future 30 F4 q' q# i$ n7 [, t. C
2. Antibody Molecular Structure 51/ C8 o7 ~+ T# v7 A6 [( C2 v
3. Glycosylation of Therapeutic IgGs 67: U9 \$ n% ~: E8 O" s8 `
4. Antibody Databases and Tools: The IMGT(? Experience 913 _ A$ W1 V0 ?; {' H: ^
PART II ANTIBODY SOURCES 115& s/ r" Z! {2 [0 O* i% E' `
5. Human Antibodies from Transgenic Mice 117
" R! p& @6 U }5 I( g4 b 6. Rabbit Hybridoma 151
3 Z+ r/ D+ A' j8 `7 m8 u) Q ^ 7. Human Antibody Repertoire Libraries 169# Z4 P* q5 K$ Q/ y1 E: m6 \# d# [, z
PART III IN VITRO DISPLAY TECHNOLOGY 189
2 M l' }. v& W; R) U 8. Antibody Phage Display 191
# V5 |/ o4 w% h+ t' G- n 9. Yeast Surface Display 213
% v4 M2 d8 B6 e' D# M3 W 10. Ribosomal Display 2394 ^( E! ]6 Z# C) Q4 W0 a$ Z$ B
11. Bacterial Display of Antibodies 255
$ l: f" r6 a4 e; G' L 12. Antibody Selection from Immunoglobulin Libraries Expressed in Mammalian Cells 2835 f$ |: h d- J/ j3 K6 f4 r
PART IV ANTIBODY ENGINEERING 309% g ?/ V0 U! o4 D
13. Antibody Engineering: Humanization, Affinity Maturation, and Selection Techniques 311( H1 Y) t$ B% S: F' w7 }* x
14. Modulation of Serum Protein Homeostasis and Transcytosis by the Neonatal Fc Receptor 335. d0 z" u5 f( v5 A
15. Engineering the Antibody Fc Region for Optimal Effector Function 349
% d* L5 F& {- F( r8 J PART V PHYSIOLOGY AND IN VIVO BIOLOGY 371# W: [9 v5 {3 ~
16. Antibody-Complement Interaction 373( B& n- w" t* [0 d5 {
17. Bacteria Immunoglobulin-Binding Proteins: Biology and Practical Applications 385
! U9 C+ k) S6 r' ~/ M" X+ S/ r 18. Immunogenicity Screening Using in Silico Methods: Correlation between T-Cell Epitope Content and Clinical Immunogenicity of Monoclonal Antibodies 417
A, X, a+ }' {1 W | 19. Monoclonal Antibody Pharmacokinetics and Pharmacodynamics 439) b) G6 o$ {/ d1 {$ @5 O
20. Biodistribution and Imaging 461
; O# [: A( V6 g# W, w 21. Antibodies and the Blood-Brain Barrier 483
5 ^6 ^* b2 j: m/ z3 v( [ PART VI ANTIBODY CHARACTERIZATION 503% p6 G# Q$ l1 p% i) Q
22. Determination of Equilibrium Dissociation Constants 505" F' }' t% f h* n3 b: L- `
23. Molecular and Functional Characterization of Monoclonal Antibodies 525
+ e+ }, x4 k* c* F. _ 24. Characterization of Heterogeneity in Monoclonal Antibody Products 541- ^7 e% @1 |0 |. l- ]% B' P: e& J
PART VII ANTIBODY EXPRESSION 555- l, ~1 A6 Q% g) Z+ z$ N- M
25. Antibody Expression in Mammalian Cells 5572 h! A9 U* Y. @ d. v! m
26. Production of Antibodies in Pichia pastoris 5730 |9 k8 j4 E9 g
27. Production of Antibody Fab' Fragments in E. coli 589
r3 a6 k/ c! h, G 28. Production of Human Therapeutic Monoclonal Antibodies in Chicken Eggs 623- ^# K- p: M5 ~
29. Production of Antibodies in Plants 651, L6 f! k! j J' ~ d6 C) C) y
PART VIII THERAPEUTIC ANTIBODIES 6734 A) p* R! M1 G8 K6 H
30. The Formulation and Delivery of Monoclonal Antibodies 675
) x* H& |" O- @ 31. Therapeutic Antibodies in Clinical Use and Leading Clinical Candidates 711
* j5 m) e* H R% `# `2 J' E6 j; @4 r 32. Follow-On Protein Products: What, Where, When, How? 763; \: h' w& S* Y
33. Monomeric Fc Fusion Molecules 779 D- \5 f2 W+ r+ I3 k8 p, @1 o
34. Radioimmunotherapy: Current Status and Future Directions 797
* ]2 Z. R* w. j 35. Antibody-Drug Conjugate Therapy 821: s1 B( U. ~$ Q9 X; P
ABBREVIATIONS 857
1 U6 p8 U" ]$ \9 f! M9 H INDEX 865
! V1 o h, T: K0 F; t8 l
# ~! a# ~% R2 Z4 Z[hide][/hide] |
附件: 你需要登录才可以下载或查看附件。没有帐号?注册
-
总评分: 包包 + 10
查看全部评分
|